<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01528202</url>
  </required_header>
  <id_info>
    <org_study_id>SLS_SUB60</org_study_id>
    <nct_id>NCT01528202</nct_id>
  </id_info>
  <brief_title>Tart Cherries and Melatonin Content</brief_title>
  <official_title>Effect of Tart Cherry Juice (Prunus Cerasus) on Melatonin Levels and Sleep Quality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northumbria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Surrey</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northumbria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this investigation was to examine the effects of tart Montmorency cherry juice on
      urinary 6-sulfatoxymelatonin and sleep quality using a double-blind, placebo-controlled,
      cross-over design.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to examine the efficacy of tart cherry juice on sleep quality,
      quantity, and timing. Naturally circulating melatonin is instrumental in regulating
      sleep/wake schedules. Tart Montmorency cherries (Prunus Cerasus) contain high levels of
      melatonin and may be a useful intervention to supplement for realignment of circadian phase
      and by increasing the robustness of circadian amplitude. In normal healthy adults, with
      experimentally induced phase advanced circadian misalignment, the administration of a 3mg
      supplement of melatonin significantly increased sleep architecture characteristics. In this
      study we want to examine the efficacy of tart cherry juice in increasing urinary levels of
      melatonin and the subsequent impact this will have on sleep parameters.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>urinary 6-sulphatoxymelatonin</measure>
    <time_frame>continually for 48 hours</time_frame>
    <description>urinary 6-sulphatoxymelatonin is the primary metabolite of melatonin and provides a sarrogate marker of melatonin metabolism. By measuring over a 48 h period it is possible to examine the circadian rhythm of melatonin.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>continually throughout the duration of the study</time_frame>
    <description>Acti watches quantitively measure sleep and activity of participants, whereas slep recall provides a retrospective and subjective m,easure of sleep quality.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Sleep</condition>
  <arm_group>
    <arm_group_label>Baseline placebo</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>measures taken before administration of placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo intervention given after 'baseline placebo' arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>baseline cherry juice</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>measures taken before the cherry juice intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cherry juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>trial where cherry juice is taken following the 'baseline cherry juice' arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cherry juice</intervention_name>
    <description>30 mLs preceding morning meal and 30 mLs preceding evening meal each day for 7 days.</description>
    <arm_group_label>cherry juice</arm_group_label>
    <other_name>CherryActive concentrate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fruit juice cordial</intervention_name>
    <description>fruit flavoured juice concentrate</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Apple and blackcurrent squash (0164 9338). Sainsbry's Supermarkets Ltd.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Equal numbers of healthy, non-pathological males and females aged between 18-39.

        Exclusion Criteria:

          -  history of epilepsy, current episode of major depressive disorder or anxiety disorder,
             or a current sleep problem or an inability to comprehend English, travel over two time
             zones within the last six months, excessive alcohol (over 3 units per day) or caffeine
             consumption (more than 6 caffeinated drinks or 1 after 6pm), a smoker, a shift worker,
             a familial history of diabetes, users of medication or supplements, or if the
             participant is pregnant or currently lactating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glyn Howatson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northumbria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northumbria University</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <state>Tyne and Wear</state>
        <zip>NE1 8ST</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2012</study_first_submitted>
  <study_first_submitted_qc>February 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2012</study_first_posted>
  <last_update_submitted>February 3, 2012</last_update_submitted>
  <last_update_submitted_qc>February 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northumbria University</investigator_affiliation>
    <investigator_full_name>Dr. Glyn Howatson</investigator_full_name>
    <investigator_title>Laboratory Director</investigator_title>
  </responsible_party>
  <keyword>Sleep, circadian cycle, melatonin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

